Stock screenerAll disclosures →
EDGAR →
TFX
Conviction 64HealthcareScan · Mon, Aug 10, 2026TFX$132.83-1.59%
ResistanceSupportVol 14Congress buyCongress sellVol MA14 613.48K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price132.83
Change-1.59%
Gap+0.56%
Rel volume1.31×
Avg volume550.16K
Avg $ vol74.46M
SMA 20134.55
SMA 50131.70
SMA 200121.45
Price vs 50+0.86%
Price vs 200+9.37%
MA stackbullish
50/200 cross—
Supertrendup · 127.21
RSI (14)48
MACD hist-0.16
MACD crossbear · 0d
Stoch %K / %D19 / 37
ADX (14)12
+DI / −DI17 / 21
RSI divergence—
MACD divergenceBearish
ATR %+3.91%
ADR %3.66%
52w high140.12
52w low100.34
From 52w high-5.20%
Above 52w low+32.38%
New 52w highNo
SqueezeOn · 13d
Bollinger width8.20%
%B0.34
Donchian pos28.35%
Donchian high145.00
Donchian low128.02
AVWAP (52w high)136.45
vs AVWAP high-2.65%
AVWAP (52w low)121.30
vs AVWAP low+9.51%
OBV trendFlat
Chaikin MF (20)-0.20
Today vs 20d1.31×
Avg vol (14d)613.48K
Avg vol (20d)550.16K
Avg $ vol (20d)74.46M
Market cap5.63B
RS 3m (vs SPY)-3.19%
RS 6m (vs SPY)+13.36%
RS line new highNo
Trend template7/8
Technical rank58.4
1 week-4.92%
1 month-2.14%
3 months-0.17%
6 months+22.51%
1 year+15.01%
YTD+8.52%
P/E-6.21
P/B1.94
P/S2.82
P/FCF3892.34
EPS-20.25
Div yield1.07%
ROE-31.18%
ROA-13.34%
Debt/Eq0.97
Current2.60
EV/EBITDA27.48
Gross margin56.24%
Net margin-45.45%
Rev growth17.25%
EPS growth-1399.81%
Price target154.63
Target upside16.41%
Analyst ratingBuy
Institutional122.48%
Ent. value8.14B
Revenue570.33M
Net income99.69M
Gross profit331.71M
Free cash flow1.45M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNYSE
Shares out44.27M
Employees15.5K
ListedThu, Jun 1, 1972
Free float43.4M
Float %98.1%
Short interest2.78M
Days to cover6.2d
Short volume62.3%
Squeeze score57 / 100
Next earnings—
EPS forecast—
Last EPS vs est$1.76 vs $1.28
Last surprise+37.5% beat
Setup gradeB
Conviction64 / 100
Pattern quality—
Tech rank58.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance144.60
Support122.87
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upJul 301 scan
- Breaking out nowJul 311 scan
- Broke outAug 3 – Aug 42 scans
Congress activity
Disclosed STOCK Act trades in TFX · 3 recent
Insider activity
SEC Form 4 transactions in TFX · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Weidman Jason R. President and CEO · Common Stock · 2026-06-08 | Grant | 53.98K | $0 | 2026-06-08 | 2026-06-09 |
RANDLE STUART A Director · Common Stock · 2026-06-08 | Grant | 4.66K | $0 | 2026-06-08 | 2026-06-09 |
Weidman Jason R. President and CEO · Stock Option / (Right to Buy) · 2026-06-08 | Grant | 26.07K | $0 | 2026-06-08 | 2026-06-09 |
RANDLE STUART A Director · Stock Option / (Right to Buy) · 2026-06-08 | Grant | 2.19K | $0 | 2026-06-08 | 2026-06-09 |
RANDLE STUART A Director · Common Stock · 2026-06-08 | Grant | 995 | $0 | 2026-06-08 | 2026-06-09 |
RANDLE STUART A Director · Common Stock · 2026-06-07 | Tax | 4.05K | $526K | 2026-06-07 | 2026-06-09 |
TOKICH MICHAEL J Director · Stock Option / (Right to Buy) · 2026-05-15 | Grant | 4.79K | $0 | 2026-05-15 | 2026-05-19 |
Duncan Candace H Director · Stock Option / (Right to Buy) · 2026-05-15 | Grant | 2.4K | $0 | 2026-05-15 | 2026-05-19 |
Krakauer Andrew A Director · Stock Option / (Right to Buy) · 2026-05-15 | Grant | 2.4K | $0 | 2026-05-15 | 2026-05-19 |
Duncan Candace H Director · Common Stock · 2026-05-15 | Grant | 1.09K | $0 | 2026-05-15 | 2026-05-19 |
SEC filings
EDGAR filings in TFX · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.